Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | PIM1 | P11309 | 2/20 | 0.41 |
| ▸ | KDM1A | O60341 | 2/20 | 0.40 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.40 |
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.39 |
| ▸ | XDH | P47989 | 1/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.37 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.37 |
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.36 |
| ▸ | TNKS | O95271 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PDE9A | O76083 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13170990 | 0.93 | CA1 (0.45) | CA1CA2PIM1PDPK1SLC22A12 | |
| SCHEMBL13170986 | 0.93 | CA1 (0.45) | CA1CA2PIM1PDPK1SLC22A12 | |
| SCHEMBL13171022 | 0.93 | CA1 (0.50) | CA1CA2PIM1PDPK1SLC22A12 | |
| SCHEMBL13170993 | 0.92 | CA1 (0.50) | CA1CA2PIM1PDPK1SLC22A12 | |
| SCHEMBL13170988 | 0.91 | CA1 (0.49) | CA1CA2PIM1PDPK1SLC22A12 | |
| SCHEMBL13170976 | 0.91 | CA1 (0.49) | CA1CA2PIM1PDPK1SLC22A12 | |
| SCHEMBL13171020 | 0.90 | CA1 (0.44) | CA1CA2PIM1KDM1APDPK1 | |
| SCHEMBL13170980 | 0.89 | ADRA2C (0.43) | CA1CA2PIM1SLC22A12XDH | |
| SCHEMBL13171002 | 0.89 | CA1 (0.42) | CA1CA2PIM1PDPK1SLC22A12 | |
| SCHEMBL13192364 | 0.87 | PDPK1 (0.44) | CA1CA2PIM1KDM1APDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9512137-B2 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-12-06 | — | — | US | disclosed |
| US-20120256172-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120256172-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | SLC25A21, SLC25A11, SLCO4C1 | CA1 3983/4885CA2 2855/4885PIM1 2897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.